Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
0.7422
-0.0562 (-7.04%)
At close: Feb 20, 2026, 4:00 PM EST
0.7113
-0.0309 (-4.16%)
After-hours: Feb 20, 2026, 6:06 PM EST
Decoy Therapeutics Employees
Decoy Therapeutics had 2 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,502,379
Market Cap
4.74M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2023 | 2 | -10 | -83.33% | 2 | 0 |
| Dec 31, 2022 | 12 | -4 | -25.00% | 12 | 0 |
| Dec 31, 2021 | 16 | 7 | 77.78% | 16 | 0 |
| Dec 31, 2020 | 9 | 1 | 12.50% | 7 | 2 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Calidi Biotherapeutics | 28 |
| VivoSim Labs | 14 |
| Genprex | 13 |
| Processa Pharmaceuticals | 10 |
| MetaVia | 9 |
| Aprea Therapeutics | 8 |
| Acurx Pharmaceuticals | 4 |
| Xenetic Biosciences | 2 |
DCOY News
- 9 days ago - Decoy Therapeutics Joins Webull Corporate Connect Service Platform - PRNewsWire
- 15 days ago - Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial - PRNewsWire
- 16 days ago - Decoy Therapeutics Participates in Virtual Investor "What This Means" Segment Highlighting Recently Announced Global Access Commitment Agreement - PRNewsWire
- 5 weeks ago - Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform - PRNewsWire
- 6 weeks ago - Salarius Pharmaceuticals Changes Corporate Name to Decoy Therapeutics and Nasdaq Ticker Symbol to DCOY Reflecting Focus on Next-Generation Peptide Conjugate Therapeutics - GlobeNewsWire
- 2 months ago - Salarius Pharmaceuticals Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting - GlobeNewsWire
- 2 months ago - Salarius Pharmaceuticals Announces Planned Corporate Name and Ticker Symbol Change to Decoy Therapeutics, Reflecting Strategic Pivot to Next-Generation Antiviral and Peptide-Conjugate Platform - GlobeNewsWire
- 2 months ago - Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian Flu Study - GlobeNewsWire